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LETTERS TO THE EDITOR
IMMUNOLOGY
THE O
FJOURNAL
Comment on “CCR7 Is Critically
Important for Migration of
Dendritic Cells in Intestinal Lamina
Propria to Mesenteric Lymph
Nodes”
T he recent paper by Jang et al. (1), highlighted in In ThisIssue (2), is part of a recent rediscovery of the myeloidcompartment of the intestinal lamina propria, which is
probably the largest macrophage population in the body. The
authors refer to these cells as dendritic cells, based on their ex-
pression of surface markers such as CD11c, but a dendritic cell
was originally defined as a cell that can present Ag to naive T
cells. The large majority of the stellate (or dendritic) cells of the
intestinal lamina propria expresses the macrophage-specific
F4/80 Ag, which is lost from mature Ag-representing cells, and
also expresses the CSF-1 receptor and aCSF-1R-EGFP reporter
gene (3) (see images of F4/80 and CSF-1R online www.
macrophages.com). The majority of the so-called dendritic
cells of the lamina propria is clearly phagocytic (1). Some 15
years ago, the myeloid cells of mouse lamina propria were iso-
lated, and the cells that could actually stimulate naive T cells in
a MLR were selectively enriched in the nonphagocytic popula-
tion (4). By contrast, the F4/80-positive phagocytes, which
were also strongly class II-MHC-positive, caused indomethacin-
sensitive repression of T cell activation. It is inescapable that the
large majority of the cells studied by Jang et al. (1) are not den-
dritic cells by the functional definition, and there is no evidence
that all, or indeed any, of them ever become cells that can
present Ag to naive T cells. They are the lamina propria
macrophages. They might acquire Ag-presenting activity. On
the other hand, they might actually be more important to the
maintenance of tolerance.
David A. Hume
Australian Research Council Special Research Centre
for Functional and Applied Genomics
Institute for Molecular Bioscience
University of Queensland
Brisbane, Australia
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Response to Comment on “CCR7 Is
Critically Important for Migration of
Dendritic Cells in Intestinal Lamina
Propria to Mesenteric Lymph Nodes”
I n response to a letter by Dr. David Hume (1), we wouldlike to point out that the following lines of evidence clearlyindicate that the lamina propria dendritic cells (LP-DC)
we reported (2) are indeed DC but not macrophages. As seen in
Fig. 1A in our recent analysis in which we used a 17.5% Accu-
denz solution instead of the original 15.5% solution to enrich
for light-density cells such as macrophages and DC from the
small intestinal LP, CD11chighCD11blow (R1) and
CD11chighCD11bhigh (R2) cell populations with dendritic
morphology were abundantly found and were strongly positive
for a DC-specific marker, DEC-205. With regard to F4/80 ex-
pression, R1 subset was clearly negative, but R2 was moderately
positive. Functional analysis revealed that both R1 and R2 sub-
sets can present alloantigen to naive T cells just as effectively as
splenicDCand lymphnodeDC (Fig. 1B, left column) and can also
present OVA efficiently toOVA-TCR expressing T cells (Fig. 1B,
right column). Thus, these DEC-205 LP-DC have the hallmark
of DC, i.e., potent Ag-presenting abilities to T cells.
Then, are the intestinal F4/80-positive, MHC class II-posi-
tive phagocytic macrophages described by Dr. Hume’s group
(3) also found in our analysis? The answer seems yes. They ap-
pear to represent CD11cintCD11bhigh cell population (R3) be-
cause they are strongly F4/80 positive, DEC-205 negative (Fig.
1A), and also strongly positive for MHC class II expression
(data not shown). Although this cell population was hardly de-
tectable in our original analysis (2), the use of 17.5% Accudenz
solution instead of 15.5% solution in the present series of anal-
ysis allowed us to visualize such cells.
Collectively, by functional definition, LP-DC (2) are indeed
DC with potent Ag-presenting abilities. Dr. Hume’s finding
(3) is also correct that macrophages are present in substantial
numbers in the small intestinal LP, but they appear clearly dis-
tinguishable from the LP-DC (2).
Myoung Ho Jang and Masayuki Miyasaka
Laboratory of Immunodynamics
Department of Microbiology and Immunology
Osaka University Graduate School of Medicine
Osaka, Japan
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Comment on “Cutting Edge: Anti-
CD25 Monoclonal Antibody
Injection Results in the Functional
Inactivation, Not Depletion, of
CD4CD25 T Regulatory Cells”
I n a recent article, Kohm et al. (1) make a case for the invivo administration of anti-CD25 leading to a functionalinactivation of CD4CD25 regulatory T cell (Treg),
rather than their deletion as has been previously assumed. The
majority of the data in the Kohm et al. article comes from the
use of the 7D4 (rat IgM) Ab. We believe it is important to em-
phasize that, overwhelmingly, “Treg depletion” studies use a
different clone, PC61 (rat IgG1). Kohm et al. suggest that
down-modulation of CD25 after Ab treatment could lead to a
misinterpretation that CD25-expressing cells are removed.
This may be the case when using 7D4. However, using FACS
analysis at the single cell level, we have previously reported that
PC61 administration leads to a rapid and dramatic loss of
CD25Foxp3 cells without a corresponding increase in
CD25Foxp3 cells (2). These data lead inevitably to the conclu-
sion that the commonly used PC61 Ab does, in fact, deplete
CD25-expressing Treg.
So we are left with the interesting situation of two anti-CD25
Abs having very different effects. This is perhaps not surprising
given their difference in isotype. These differences seem to be
reflected in disease. Kohm et al. have previously reported that
7D4 does not influence the course of experimental autoim-
mune encephalomyelitis (EAE) after optimal immune priming
(3, 4), whereas their most recent data do show exacerbation
when priming is suboptimal (1). In contrast, we and others have
found PC61 treatment to exacerbate/prolong EAE after both
optimal and suboptimal priming (2, 5–7). As a whole, these
studies indicate that Treg do have a controlling influence over
optimal disease, and their removal using PC61 allows for an
increase in severity and/or failure to recover. 7D4 appears not to
achieve this, but perhaps perturbs the Treg/T-aggressor balance
sufficiently to allow the conversion of silent autoimmunity into
overt autoaggression in the setting of suboptimal priming. It
will be important to dissect the mechanisms underlying disease
modification in both these settings.
Leigh A. Stephens and Stephen M. Anderton
Institute of Immunology and Infection Research
School of Biological Sciences
University of Edinburgh
Edinburgh, United Kingdom
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Comment on “Cutting Edge: Anti-
CD25 Monoclonal Antibody
Injection Results in the Functional
Inactivation, Not Depletion, of
CD4CD25 T Regulatory Cells”
T he injection of anti-CD25mAb to deplete CD25 reg-ulatory T cells (TR) in mice has been common practiceto infer the function of TR. In a recent report, Kohm et
al. (1) claimed that injection of anti-CD25 mAb in mice results
in the functional inactivation, not depletion, of CD4CD25
TR. This conclusion was based on the analysis of mice that re-
ceived the rat-IgM 7D4 mAb or the rat IgG PC61. CD25 and
FOXP3 expression was determined by FACS analysis after 7D4
treatment but solely by RT-PCR after PC61 administration
Figure 1. CD11chigh subsets in the small intestinal LP are DC but not
macrophages. A, Low-density lamina propria cells were isolated from the
BALB/c small intestine using a 17.5% Accudenz gradient. Enriched cells
were stained for CD11b, CD11c, DEC-205, and F4/80 and analyzed by
flow cytometry. Several CD11c subsets could be recognized on the basis
of their different CD11c/CD11b expression patterns: CD11chighCD11blow
(R1), CD11chighCD11bhigh (R2), CD11cintCD11bhigh (R3), and
CD11clowCD11bhigh (R4; consisting of mainly eosinophils). Histogram
FACS profiles shown on the right were acquired after gating on the R1, R2,
and R3 subsets. Shaded, isotype controls; open, stained for DEC-205 or
F4/80. B, LP-DC were examined for their Ag-presenting abilities. FACS-
sorted BALB/c LP-DC were either cocultured with CFSE-labeled
C57BL/6 spleen cells for 3 days (left column) or pulsed with OVA protein
first and then cocultured with CFSE-labeled OVA TCR transgenic CD4
T cells (DO11.10; 1:20) for 3 days (right column). DC from other tissues
were also treated in the same way. T cell proliferation was measured by
CFSE dilution. Numbers within histograms indicate the percentage of pro-
liferated cells.
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(1). Using FACS analysis in both cases, we enumerated
CD4CD25 and CD4FOXP3 cells in blood, spleen, and
lymph nodes isolated from mice treated with either 7D4 or
PC61 (Fig. 1). Similarly to Kohm et al., we found that despite
the disappearance of surface CD25 expression, FOXP3 cell
frequency is not affected by 7D4 administration, irrespective of
the tissue analyzed and independently of the dose used (up to 3
mg/mouse). In contrast, injection of as little as 500 g/mouse
of PC61 resulted in both the disappearance of CD25 cells and
the loss of CD4FOXP3 cells. In PBL, the frequency of CD4
cells expressing FOXP3 is reduced from an average of 8 to 3%,
indicating that 65% of the total FOXP3 cells are depleted.
The disappearing cells are the bulk of the FOXP3CD25TR,
while the pre-existing FOXP3CD25 subset appeared main-
tained. In spleen, 45% of the FOXP3 cells were depleted.
TR originally CD25
 that lost CD25 expression and pre-exist-
ing CD25TR appeared to contribute equally to the remaining
FOXP3 cell pool. In lymph nodes, depletion was less marked
and corresponded to the disappearance of 33% of the
FOXP3CD25. Increasing the amount of PC61 injected (up
to 3 mg/mouse) did not dramatically increase the depletion ef-
ficiency (data not shown). We conclude that injection of the
rat-IgG PC61mAb, which has been themost frequently used to
interfere with TR function in vivo, does result in depletion of a
large fraction of TR.
This work was supported by the Fundac¸a˜o para a Cieˆncia a
Tecnologia-Programa Operacional Cieˆncia Tecnologia e Ino-
vac¸a˜o national programs.
Santiago Zelenay and Jocelyne Demengeot
Instituto Gulbenkian de Cieˆncia
Oeiras, Portugal
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Response to Comment on “Cutting
Edge: Anti-CD25 Monoclonal
Antibody Injection Results in the
Functional Inactivation, Not
Depletion, of CD4CD25 T
Regulatory Cells”
I t is indeed important to dissect the mechanisms by whichinjection of anti-CD25 mAb may influence bothCD4CD25 regulatory T cell (TR) function and re-
sponder T cell functionality in vivo. This important need was
the motivation of the current studies. While our current study
does focus on the use of the 7D4 clone, we have observed sim-
ilar findings using the PC61 clone (see Fig. 3 of Ref. 1). How-
ever, differences do exist.
Basic immunology tells us that an Ab of the isotype of IgM
should bemore efficient in fixing complement, and hence, serve
to more efficiently deplete a target cell population. Interest-
ingly, a previous study reported that neither PC61 nor 7D4 “in-
duced a strong complement-mediated cytotoxicity” (2). We
have tested this ourselves and have found that 7D4, but not
PC61, fixes complement in vitro. Thus, we are left with the
question that if PC61 indeed cannot fix complement, then by
what mechanism does it deplete CD4CD25 TR? Based on
the capacity of fixing complement, it would seem that if either
Ab were to be successful in depleting a target cell population, it
would be the clone capable of fixing complement, i.e., 7D4. In
vitro, as determined by triple staining of target T cells to mea-
sure the expression of CD4, CD25, and intracellular Foxp3, we
have observed that CD25 expression is quickly down-regulated
following exposure to either 7D4 or PC61 in the absence of cell
depletion. In vivo, a fundamental difference between these two
clones appears as revealed by the kinetics of CD25 expression,
which is quickly down-regulated following in vivo treatment
with 7D4. In comparison, the kinetics of PC61-induced CD25
Figure 1. C57BL/6 mice (8 wk old) raised in specific
pathogen-free conditions were injected i.p. once with
anti-CD25 mAb clone 7D4 (3 mg) or PC61 (500 g).
Splenocytes, lymph node cells, and PBL were isolated
3 days after from either control or treated mice and
analyzed by flow cytometry for CD4, FOXP3, and
CD25 expression (for CD25 visualization, clone 7D4 or
PC61 was used when PC61 or 7D4 was injected, re-
spectively). A, Representative staining of splenocytes
(gated on CD4 cells) analyzed for CD25 and FOXP3
expression. Number inside dot plots represents aver-
age  SD of the percentage of FOXP3 among CD4
cells. B, Percentage of FOXP3CD25 (f) and
FOXP3CD25 () among CD4 cells. , p  0.01
for CD4FOXP3 in PC61-injected mice vs control or
7D4-injected mice. Data represent the average  SD
for each group (n 	 3). One of three independent ex-
periments is shown.
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down-regulation are slightly delayed; however, the effects ap-
pear to be longer-lasting than that of 7D4. Regardless of which
isotype is used, we often see that CD25 expression returns to
control levels within 7–10 days of the last treatment. It was this
finding that originally prompted us to investigate the alterna-
tive actions of anti-CD25 mAb treatment, as it was hard to en-
vision how the CD4CD25 TR population could return to
control levels within that time frame if the cells were physically
depleted.
We are still investigating whether injection of PC61 results in
a partial depletion of CD4CD25 TR and the potential con-
tribution that partial depletion may make to the differences in
CD25 expression kinetics between the two Ab clones.While we
cannot comment on the purported depletion of CD4CD25
TR referenced by our colleagues (3), because Stephens and
Anderton used a single dose of anti-CD25 mAb at a concentra-
tion double than we used in our studies, this difference is an
obvious source for potential differences in the outcome of anti-
CD25 mAb treatment. Furthermore, Zelenay and Demengeot
(4) only observed partial deletion of CD4CD25 TR using
PC61.Our studies have revealed that decreasing thedose of anti-
CD25 mAb treatment does decrease the duration of CD25
down-regulation.
In regards to the findings of McGeachy et al. (5) concerning
the effects of PC61 on experimental autoimmune encephalo-
myelitis progression in disease induced under “optimal” prim-
ing conditions, it would be inappropriate for us to compare our
findings to their report in light of the fact that the two model
systems use distinct strains of mice, priming Ags, and priming
protocols and that significant strain differences exist in regards
to the functionality of CD4CD25 TR. In sum, our data us-
ing clone 7D4 clearly demonstrate that CD25 down-regula-
tion, in the absence of overt CD25 TR depletion (as confirmed
by Zelenay and Demengeot, Ref. 4), is capable of inactivating
CD4CD25 TR function allowing exacerbation autoreactive
Th1 cell function and clinical experimental autoimmune en-
cephalomyelitis progression.
Adam P. Kohm and Stephen D. Miller
Department of Microbiology-Immunology
Northwestern University Medical School
Chicago, IL 60611
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Comment on “Duration and
Intensity of NF-B Activity
Determine the Severity of
Endotoxin-Induced Acute Lung
Injury”
E verhart et al. (1) reported that endotoxin-induced lungedema was completely prevented by NF-B inhibitionand incompletely by neutrophil depletion. Factors
other than pulmonary neutrophilia were also involved in the
pathogenesis of endotoxin-induced pulmonary edema, which
the authors stated are currently not well defined. Some of these
factors are well defined and are the cytokines TNF, IL-1, and
IFN- and their mediator NO. These cytokines contribute to
pulmonary edema by a reduction of alveolar sodium and chlo-
ride and associated fluid transport (2). TNF reduced epithelial
sodium channel mRNA expression in alveolar epithelial cells
(3). IL-1 was noted to reduce cystic fibrosis transmembrane
conductance regulator chloride channel function and epithelial
sodium channel expression in alveolar type II cells. IFN- re-
duced cystic fibrosis transmembrane conductance regulator
mRNA in respiratory epithelial cells (2). In meningococcal sep-
ticemia, pulmonary edema was associated with reduced epithe-
lial chloride transport (4).
NO is released by distal lung epithelial cells and alveolar mac-
rophages in response to TNF, IL-1, and IFN- (2) and reduced
sodium transport in alveolar epithelial cells (5). Neutrophil leu-
kocytes are a source of both TNF and IL-1. The lung edema in
neutrophil depleted mice was probably induced by these medi-
ators generated by cells other than neutrophils like local mac-
rophages. Future research into the effects of NF-B inhibition
on pulmonary edema needs to focus on TNF, IL-1, IFN-, and
NO production and the associated changes in alveolar ion and
fluid transport.
Michael Eisenhut
Institute of Child Health
University of Liverpool
Liverpool, United Kingdom
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